Skip to main content

Cellulose Capsules-Analternative to Gelatin

Structural, Functional and Community Aspects

  • Chapter
Biomedical Polymers and Polymer Therapeutics

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Digenis G. A., Gold T. B., and Shah V. P., 1994, Cross-Linking of Gelatin Capsules and Its Relevance to Their in Vitro-in Vivo Performance. J. Pharm. Sci., 83: 915–921.

    PubMed  CAS  Google Scholar 

  2. U.S. Department of Health and Human Services, Food and Drug Administration, Sep. 1997, Guidance for Industry “The Sourcing and Processing of Gelatin to Reduce the Potential Risk Posed by Bovine Spongiform Encephalopathy (BSE) in FDA-Regulated Products for Human Use.”

    Google Scholar 

  3. The European Agency for the Evaluation of Medical Products, Human Medicines Evaluation Unit, Oct. 1998, “Note for Guidance on Minimising the Risk of Transmitting Animal Spongiform Encephalopathy Agents via Medicinal Products.”

    Google Scholar 

  4. Jones B. E., Capsules, Hard. 1990, In Vol. 2, “Encyclopedia of Pharmaceutical Technology” (J. Swarbrick and J.C. Boylan eds.), Marcel Dekker, Inc., New York and Basel.

    Google Scholar 

  5. Nishi K., Nagata S., 1999, Characteristics of HPMC capsules. J. Pharm. Sci. Tech. Japan, 59: Suppl. p. 78, (Japanese).

    Google Scholar 

  6. Nagata S., Nishi N., and Matsuura S., 1999, Characteristics of HPMC capsules. Int. Symp. Strategies for Optimizing Oral Drug Delivery: Scientific to Regulatory Approaches (Kobe), Abst., p.161.

    Google Scholar 

  7. Matuura S. and Yamamoto T., 1993, New hard capsules prepared from water-soluble cellulose derivative. Yakuzaigaku, 53: 135–140, (Japanese).

    Google Scholar 

  8. Ogura T., Furuya Y., and Matsuura S., 1998, HPMC Capsules: An Alternative to Gelatin. Pharm. Tech. Europe, Nov.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Shunji, N. (2002). Cellulose Capsules-Analternative to Gelatin. In: Chiellini, E., Sunamoto, J., Migliaresi, C., Ottenbrite, R.M., Cohn, D. (eds) Biomedical Polymers and Polymer Therapeutics. Springer, Boston, MA. https://doi.org/10.1007/0-306-46842-5_5

Download citation

  • DOI: https://doi.org/10.1007/0-306-46842-5_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46472-0

  • Online ISBN: 978-0-306-46842-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics